Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV - Post by User

Avivagen Inc > Avivagen Presents at Kansas City Animal Health Investment Fo
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(208)
•••
Comment by StoneMan45on Sep 06, 2020 12:12pm
142 Views
Post# 31516703

RE:RE:RE:RE:RE:Avivagen Presents at Kansas City Animal Health Investment Fo

RE:RE:RE:RE:RE:Avivagen Presents at Kansas City Animal Health Investment FoWith the US trials wrapped or wrapping up and the Us dairy watching Mexico's dairy use of OxC beta....too much going on too truely believe this will remain as a small investors stock...there are going to be some major players entering here that will never look to stockhouse for information. The recent revelation that it was Neilsons Dairy that paid extra for the milk from the Mexico trials will very likely peaks a lot of interest  from other dairy farmers everywhere but obviously the results of the dairy trial have for the US dairy which are now watching Mexico's use and have initiated some further testting. 
https://www.avivagen.com/avivagen-announces-increase-in-north-american-oxc-betatm-livestock-order-following-successful-dairy-field-tests/
'...Of significant note, a large and well known global dairy processor that purchases the farm’s milk recognized the farm with three separate financial awards for the improvements in milk yield, quality, and reduced bacterial levels achieved during the test.'

It's that time for Avivagen and I'm pleasantly positioned to enjoy the ride . 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities